|
|
|
|
||||
|
|
||||||
|
|
820.250
Statistical techniques.
(a) Where
appropriate, each manufacturer shall establish and maintain procedures for
identifying valid statistical techniques required for establishing,
controlling, and verifying the acceptability of process capability and
product characteristics. (b) Sampling
plans, when used, shall be written and based on a valid statistical
rationale. Each manufacturer shall establish and maintain procedures to
ensure that sampling methods are adequate for their intended use and to ensure
that when changes occur the sampling plans are reviewed. These activities
shall be documented. Interpretation:
When assuring that components and other products
meet acceptance criteria, manufacturers may test either all components or may
test a portion of the components using a sampling plan based upon an
acceptable statistical rationale (820.250). A manufacturer shall be prepared
to demonstrate the statistical rationale for any sampling plan used. Plans
should be developed by qualified mathematicians or statisticians, or be taken
from established standards such as ANSI Z1.4. It should be recognized that
all sampling plans have a built-in risk of accepting a bad lot. This sampling risk is typically determined in
quantitative terms by deriving the "operating characteristic curve"
for the selected plan. Each sampling plan has a characteristic curve. ANSI
Z1.4 contains operating characteristic curves for sampling plans presented in
the standards, and it can be used to determine the risk a sampling plan presents.
A manufacturer should be aware of the risks the chosen plan presents.
Operating characteristic curves are a means of graphically showing the
relationship between the:
|
|
|
|||
|
|
|
|
||||
|
Reference: www.FDA.gov The information provided here is for "public consumption" and is open to interpretation. MedicalDeviceSchool.com is not responsible for the content or the accuracy of the information. For all official interpretation and accuracy we ask that you consult the FDA's website directly and that you consult with your legal and regulatory experts on all matters of interpretation. |
|
|
||||
|
|
|
|
|
|
|
|